Homozygous deletion of MKK4 in ovarian serous carcinoma - PubMed (original) (raw)
doi: 10.4161/cbt.5.6.2675. Epub 2006 Jun 9.
Affiliations
- PMID: 16627982
- DOI: 10.4161/cbt.5.6.2675
Free article
Homozygous deletion of MKK4 in ovarian serous carcinoma
Kentaro Nakayama et al. Cancer Biol Ther. 2006 Jun.
Free article
Abstract
Analysis of deleted chromosomal regions in tumors has historically led to the identification of tumor suppressor genes. In this study, we used digital karyotyping, a genome-wide, high-resolution technology, to search for chromosomal deletions in ovarian serous carcinoma, the most lethal gynecological malignancy in women. Five purified ovarian serous carcinomas were analyzed by digital karyotyping and small interstitial deletions at chromosome 17p were identified in two tumor samples. Aligning these two deletions identified an overlapping region that spanned 2.4 Mb which harbored a candidate tumor suppressor gene, mitogen-activated protein kinase kinase-4 (MKK4). Dual-color FISH analysis confirmed homozygous deletion of the MKK4 locus in both samples and RT-PCR demonstrated that both carcinomas lacked MKK4 transcript expression. Loss of heterozygosity of 17p occurred in 24 (86%) of 28 high-grade serous carcinomas including both cases with homozygous MKK4 deletion. Additionally, downregulation of MKK4 expression was found in 96 (75%) of 128 ovarian serous carcinomas as compared to benign ovarian tissues. These findings suggest that homozygous deletion or reduced expression of MKK4 may contribute to the development of ovarian serous carcinoma.
Similar articles
- Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.
Kuo KT, Guan B, Feng Y, Mao TL, Chen X, Jinawath N, Wang Y, Kurman RJ, Shih IeM, Wang TL. Kuo KT, et al. Cancer Res. 2009 May 1;69(9):4036-42. doi: 10.1158/0008-5472.CAN-08-3913. Epub 2009 Apr 21. Cancer Res. 2009. PMID: 19383911 Free PMC article. - Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
Chae KS, Ryu BK, Lee MG, Byun DS, Chi SG. Chae KS, et al. Eur J Cancer. 2002 Oct;38(15):2048-57. doi: 10.1016/s0959-8049(02)00147-8. Eur J Cancer. 2002. PMID: 12376211 - Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.
Birch AH, Arcand SL, Oros KK, Rahimi K, Watters AK, Provencher D, Greenwood CM, Mes-Masson AM, Tonin PN. Birch AH, et al. PLoS One. 2011;6(12):e28250. doi: 10.1371/journal.pone.0028250. Epub 2011 Dec 6. PLoS One. 2011. PMID: 22163003 Free PMC article. - Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
Kurman RJ. Kurman RJ. Ann Oncol. 2013 Dec;24 Suppl 10:x16-21. doi: 10.1093/annonc/mdt463. Ann Oncol. 2013. PMID: 24265397 Review. - Role of mitogen-activated protein kinase kinase 4 in cancer.
Whitmarsh AJ, Davis RJ. Whitmarsh AJ, et al. Oncogene. 2007 May 14;26(22):3172-84. doi: 10.1038/sj.onc.1210410. Oncogene. 2007. PMID: 17496914 Review.
Cited by
- Evaluation of the association between the -1304T>G polymorphism in the promoter of the MKK4 gene and the risk of colorectal cancer: a PRISMA-compliant meta-analysis.
Bai R, Yuan C, Zhou F, Ni L, Gong Y, Xie C. Bai R, et al. Ann Transl Med. 2019 Apr;7(7):144. doi: 10.21037/atm.2019.03.08. Ann Transl Med. 2019. PMID: 31157265 Free PMC article. - MEK and the inhibitors: from bench to bedside.
Akinleye A, Furqan M, Mukhi N, Ravella P, Liu D. Akinleye A, et al. J Hematol Oncol. 2013 Apr 12;6:27. doi: 10.1186/1756-8722-6-27. J Hematol Oncol. 2013. PMID: 23587417 Free PMC article. Review. - Mechanisms of ovarian cancer metastasis: biochemical pathways.
Nakayama K, Nakayama N, Katagiri H, Miyazaki K. Nakayama K, et al. Int J Mol Sci. 2012;13(9):11705-11717. doi: 10.3390/ijms130911705. Epub 2012 Sep 18. Int J Mol Sci. 2012. PMID: 23109879 Free PMC article. Review. - Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.
Shao N, Wang Y, Lu K, Jiang WY, Li Q, Wang N, Feng NH, Hua LX. Shao N, et al. J Cancer Res Clin Oncol. 2012 Sep;138(9):1531-9. doi: 10.1007/s00432-012-1226-y. Epub 2012 Apr 24. J Cancer Res Clin Oncol. 2012. PMID: 22526163 - Digital karyotyping: an update of its applications in cancer.
Salani R, Chang CL, Cope L, Wang TL. Salani R, et al. Mol Diagn Ther. 2006;10(4):231-7. doi: 10.1007/BF03256461. Mol Diagn Ther. 2006. PMID: 16884326
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous